The possibility that Huntington's chorea might be due to a genetically determined biochemical derangement has been raised on a number of occasions. In 1963, Kenyon and Hardy suggested that abnormalities of magnesium metabolism might account for some of the features of Huntington's chorea and in a group of patients investigated the cellular magnesium levels using the Szvenk-Fekete titration method and a modification of the method of Baron and Bell (1957) . They found raised intracellular levels of magnesium and calcium compared with a control group. However Bruyn, Mink, and Calje in 1965 reviewed the literature on this subject. They conducted tests on the magnesium levels in 35 patients with Huntington's chorea using a modification of Mann and Yoe's (1956) method, and found that the levels were all within normal limits. Nielsen and Butt in 1955, The patients' condition was assessed before commencing penicillamine, and an attempt was made to rate the degree of disability on a scale as set out in Table I . A over a two-week period and maintained at this level. At the end of six months the assessment described above was repeated.
RESULTS
A comparison of the scores before and after six months' treatment is shown in Table fl . tape recording was made to assess speech using set pieces of reading material, and the patients' gait and severity of chorea were rated. The patients' weight was noted. It was hoped in this way that these indices would provide an objective assessment of any improvement that might occur. A full blood count was performed and the urine tested for albumin. These were repeatedfortnightly throughout the trial, since adverse side effects have been noted, e.g., nephrosis (Adams, Goldman, Maxwell, and Latta, 1964) and leucopenia and agranulocytosis (Corcos, Saler-Bechara, Mayer, Freyberg, Goldstein, and Jaffe, 1964; Conway and Walker, 1962) in patients with Wilson's disease on long-term treatment. The patients were also given pyridoxine 50 mg. daily throughout the trial since penicillamine has been noted to have an anti-pyridoxine effect in man (Jaffe, Altman, and Merryman, 1964 Magnesium levels in the cells and serum of both patients with Huntington's chorea and control groups were all within normal limits (Tables III and  IV) . There was no statistical difference between the two groups. The mean value of the erythrocyte magnesium levels for the Huntington's chorea group was 4-42 mEq./l. and for the controls 4-47 mEq./l., the mean of the packed cell volume (P.C.V.) for the two groups being identical at 41-2 %.
The assessment of the patients on the trial of penicillamine shows that in the first patient deterioration had continued uninfluenced by the administration of a chelating agent. In the second patient there was a slight improvement over the six-month period but on the rating scale used this was not a significant change. However,, the second patient did show a marked gain in weight (19 lb. in six months); 
DISCUSSION
The results of estimating intracellular magnesium levels in both the control groups and the group with Huntington's chorea showed no significant deviation from the normal level, all levels falling between 3-6 mEq./l. and 5 6 mEq./l., the mean being 4-42 mEq./l. This confirms the findings of Bruyn et al. (1965) who found no abnormal magnesium levels in a group of patients with Huntington's chorea. Penicillamine has been used in a number of conditions, chiefly associated with heavy metal poisoning. In view of the absence of abnormal magnesium levels any beneficial action that occurred could not be put down to this. In Wilson's disease the dose required has been found to vary between 600 and 4,000 mg./day, the average patient requiring 1,200 mg. daily to maintain them in negative copper balance. Treatment may need to go on for a year before much improvement is seen.
In cystinuria the rationale for the use of penicillamine is based upon the respective solubilities of cystine, cysteine, penicillamine, and their disulphides. However, cystinuric patients excrete less cysteine when given penicillamine whereas normal patients excrete 10 times more, and there must therefore be a further factor involved. Any action which is beneficial in Huntington's chorea must at this juncture remain speculative. It is known that D-penicillamine has metal-binding properties: it makes -SH bonds available in tissue enzyme systems. Penicillamine has also been shown to have growth-promoting properties in the chick and pig (Taylor and Gordon, 1955 )-Twenty-four-hour urinary excretion of xanthurenic acid and kynurenine is increased. Penicillamine may act in part by supplying sulphydryl groups to replace those that may be blocked by copper in Wilson's disease. In Huntington's chorea there is presumably an enzymatic disturbance and it may well be that some enzyme systems are blocked and can be persuaded to function more efficiently by this activity. Penicillamine also has an immuno-suppressive effect (Tobin and Altman, 1964) and these workers suggest that these effects may be intracellular. There are thus a number of mechanisms whereby penicillamine might act.
Turning to the patients under treatment, the first patient had undoubtedly continued to deteriorate during the six months. His score on the scale was 32 before treatment and 61 after. He A pilot trial of penicillamine in the treatment of Huntington's chorea on two patients showed mild improvement in one after six months but deterioration continued unabated in the other. Possible mechanisms by which penicillamine might be operating are discussed.
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At one year follow-up, patient 2, who had shown improvement, now has a rating score of 48 (a deterioration of 21 points) and his weight has dropped to 6st. 61b., a change of -2st. 61b., following an episode of pneumonia. One must conclude, therefore, that penicillamine in this case has brought at best a temporary improvement only in the patient's condition.
